SH3GL3
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1584205679rs17841192CTrs178411924.22E-04ALDOSTERONEBIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENINBlood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_drug
1584235930rs2562769GTrs25627692.95E-04ATORVASTATINSERINE ENDOPEPTIDASES|PYRROLES|PCSK9 PROTEIN, HUMAN|HEPTANOIC ACIDS|APOLIPOPROTEINS E|PROPROTEIN CONVERTASESResponse to statin treatment (atorvastatin), change in cholesterol levelsHPOID:0001626DOID:1287AintronGWASdb_drug
1584257351rs7182482GArs71824823.06E-04ATORVASTATINSERINE ENDOPEPTIDASES|PYRROLES|PCSK9 PROTEIN, HUMAN|HEPTANOIC ACIDS|APOLIPOPROTEINS E|PROPROTEIN CONVERTASESResponse to statin treatment (atorvastatin), change in cholesterol levelsHPOID:0001626DOID:1287GintronGWASdb_drug
1584129515rs6602977AGrs66029779.47E-05Orofacial cleftsHPOID:0000202DOID:0050567GintronGWASdb_trait
1584135138rs9920377GArs99203776.37E-04Response to taxane treatment (placlitaxel)HPOID:0100526DOID:1324AintronGWASdb_trait
1584173859rs10906975AGrs109069753.59E-04Body mass indexHPOID:0001507DOID:9970GintronGWASdb_trait
1584173859rs10906975AGrs109069754.96E-04Body mass indexHPOID:0001507DOID:9970GintronGWASdb_trait
1584178679rs1491579TCrs14915791.47E-05Alcohol consumptionHPOID:0000707DOID:1574|DOID:0050741TintronGWASdb_trait
1584179115rs12905964CTrs129059648.63E-05Alcohol consumptionHPOID:0000707DOID:1574|DOID:0050741CintronGWASdb_trait
1584201446rs2732150TCrs27321504.86E-04Coronary Artery DiseaseHPOID:0001677DOID:3393TintronGWASdb_trait
1584203402rs2642820AGrs26428206.10E-06Urinary metabolitesHPOID:0000079DOID:557AintronGWASdb_trait
1584205565rs2201101GTrs22011018.73E-05Blood PressureHPOID:0011025DOID:10763TintronGWASdb_trait
1584205679rs17841192CTrs178411924.22E-04Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption)HPOID:0011025DOID:10763CintronGWASdb_trait
1584235930rs2562769GTrs25627692.95E-04Response to statin treatment (atorvastatin), change in cholesterol levelsHPOID:0001626DOID:1287AintronGWASdb_trait
1584235930rs2562769GTrs25627691.10E-05Urinary metabolitesHPOID:0000079DOID:557AintronGWASdb_trait
1584242585rs12900490TCrs129004902.90E-05Urinary metabolitesHPOID:0000079DOID:557TintronGWASdb_trait
1584257351rs7182482GArs71824823.06E-04Response to statin treatment (atorvastatin), change in cholesterol levelsHPOID:0001626DOID:1287GintronGWASdb_trait
1584263750rs2562764CTrs25627644.57E-04Multiple complex diseasesHPOID:0000118NAAintronGWASdb_trait
1584273405rs17158772AGrs171587724.40E-07Urinary metabolitesHPOID:0000079DOID:557AintronGWASdb_trait
1584274980rs1896796AGrs18967960.000171SchizophreniaHPOID:0100753DOID:5419TintronGWASdb_trait
1584286492rs2562784AGrs25627846.00E-08HeightHPOID:0000002NATintronGWASdb_trait
Disease associated variation - OMIM
Ensembl_gene_ID Approved Gene Symbol MIM Number
ENSG00000140600.16 SH3GL3 603362